Global Hematology Analyzers and Reagents Market By Product & Services (Hematology Products & Services, Hemostasis Products & Services, Immunohematology Products & Services, Plasma Protein Analyzer, Haemoglobin Analyzers, Erythrocyte Sedimentation Rate Analyzer, Coagulation Analyzer, Flow Cytometers, Differential Counters), Price Range (High-End, Mid-Range, Low-End), Application (Anemia, Blood Cancer, Hemorrhagic Conditions, Infection-Related Conditions, Immune System Related Conditions, Others), End User (Hospital Laboratories, Blood Banks, Commercial Service Providers, Government Reference Laboratories, Research & Academic Institute, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa), Industry Trends and Forecast to 2027
Market Analysis and Insights: Global Hematology Analyzers and Reagents Market
Hematology analyzers and reagents market is expected to account to USD 6078.21 million by 2027 expanding at a rate of 6.93% in the forecast period of 2020 to 2027. High preferences for automated instrumentation and advanced technologies available for hematology analysis are expected to be the major drivers behind this market growth.
Hematology analyzers and reagents are the healthcare products and consumables designed to identify and count the individual blood cells in a highly efficient and high speed manner. These instruments have replaced the traditional methods of counting blood cells individually under a microscope that was carried out previously by the lab technicians. These devices provide more accurate and efficient results in relation to blood cell and other related information from the blood sample.
Rising volume of blood donation volume in combination with high prevalence of blood disorders are acting as major drivers for the market. Innovations and advancements in technology such as the integration of hematology analyzers with flow cytometry instrumentations are enhancing the market’s potential for growth. Increasing focus of market players on the development of high throughput analysing instruments along with the focus on developing highly sensitive point-of-care test instruments and products are also acting as major growth drivers for hematology analyzers and reagents market.
Lack of preference, resulting in slow adoption rate of this instrumentation from the developing regions of the world is acting as restrictors for the market growth. Increasing concerns amongst consumers regarding the safety and effectiveness of these devices amid recent product recalls by the major market players.
This hematology analyzers and reagent market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Hematology Analyzers and Reagents Market Scope and Market Size
Hematology analyzers and reagents market is segmented on the basis of product & services, price range, application and end user. Each individual segment’s growth is analysed and these insights are subsequently considered before providing you with the market overview which can help you in understanding and identification of your core applications in the broad market.
On the basis of product & services, the hematology analyzers and reagents market has been segmented into hematology products & services, hemostasis products & services, immunohematology products & services, plasma protein analyzer, haemoglobin analyzers, erythrocyte sedimentation rate analyzer, coagulation analyzer, flow cytometers and differential counters. Hematology products & services have been sub-segmented into instruments, reagents & consumables and services. Instruments have been sub-segmented into 5-part & 6-part fully automated hematology analyzers, 3-part fully automated hematology analyzers, semi-automated hematology analyzers, point-of-care testing hematology analyzers and highly complex clinical laboratory analyzer. Reagents & consumables have been sub-segmented into hematology reagents, slide strainers/makers, controls & calibrators and consumables. Hemostasis products & services have been sub-segmented into instruments, reagents & consumables and services. Immunohematology products & services have been sub-segmented into instruments, reagents & consumables and services.
Based on price range, the hematology analyzers and reagnets market has been segmented into high-end, mid-range and low-end.
Hematology analyzers and reagents market has been segmented on the basis of application into anemia, blood cancer, hemorrhagic conditions, infection-related conditions, immune-system related conditions and others.
Hematology analyzers and reagents market has also been segmented into hospital laboratories, blood banks, commercial service providers, government reference laboratories, research & academic institute and others based on end user.
Hematology Analyzers and Reagents Market Country Level Analysis
Hematology analyzers and reagents market is analysed and market size information is provided by country, product & services, price range, application and end user as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific in the Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa as a part of Middle East & Africa, Brazil, Argentina and Rest of South America as part of South America.
North America will account for the largest share of hematology analyzers and reagents market, amid high presence of individuals suffering from various blood-related disorders along with the high growth witnessed in blood transfusions carried out in the region. Asia-Pacific will witness the highest growth rate caused by the governments of these regions imposing favourable regulations and compliances for the consumption of advanced medical instrumentations.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Hematology analyzers and reagents market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hematology analyzers and reagents market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hematology analyzers and reagents market. The data is available for historic period of 2010 to 2018.
Competitive Landscape and Hematology Analyzers and Reagents Market Share Analysis
Hematology analyzers and reagents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to hematology analyzers and reagents market.
The major players covered in the report are Sysmex Corporation, Danaher, NIHON KOHDEN CORPORATION, Siemens Healthcare GmbH, Abbott, Boule Diagnostics, Bio-Rad Laboratories, Inc., Biosystems S.A., Diatron, EKF Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Erba Mannheim, Ortho Clinical Diagnostics, Abaxis, Heska Corporation, F. Hoffmann-La Roche Ltd, HORIBA, Ltd., Neomedica among other players domestic and global. Market share data is available for Global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Hematology Analyzers and Reagents Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.